fazarabine has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krynetskaia, NF; Krynetskiy, E; Mishra, AK; Phadke, MS | 1 |
| Abbruzzese, JL; Ajani, JA; Daugherty, K; Hubbard, KP; Levin, B; Pazdur, R | 1 |
| Esparza, L; Holmes, FA; Hortobagyi, GN; Theriault, RL; Walters, RS | 1 |
2 trial(s) available for fazarabine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Phase II trial of fazarabine in advanced colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Humans; Male; Middle Aged | 1992 |
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Breast Neoplasms; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged | 1992 |
1 other study(ies) available for fazarabine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Lung Neoplasms | 2009 |